N. Rivera (Stockholm, Sweden), V. Kouranos (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Human dendritic cells with PD-1+ CD80+ expression from lymph nodes aspirates of sarcoidosis patients.
E. Rutkowska (Józefoslaw, Poland), I. Kwiecien (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzepecki (Warsaw, Poland)
|   |
Is there a link between autophagy, sarcoidosis, and non granulomatous neurological disorders?
T. El Jammal (Lyon, France), A. Calender (Bron, France), N. Freymond (Pierre Bénite, France), G. Prévot (Toulouse, France), P. Sève (Lyon, France), D. Valeyre (Bobigny, France), Y. Pacheco (Lyon, France)
| |
Mitophagy, at the crossroads of genetic pathways involved in sarcoidosis and host-pathogen interactions with SARS-COV2 proteins
A. Calender (Lyon, France), D. Valeyre (Paris, France), J. Lamartine (Lyon, France), F. Chevalier (Lyon, France), D. Sigaudo Roussel (Lyon, France), Y. Pacheco (Lyon, France)
| |
Cryptococcosis in a sarcoidosis patient with impaired response to IL-2
T. El Jammal (Lyon, France), A. Calender (Bron, France), N. Freymond (Pierre Bénite, France), P. Sève (Lyon, France), Y. Pacheco (Lyon, France)
| |
The role of nonspecific inflammation factors – SA-A and pentraxin-3 in patients with respiratory sarcoidosis in different age groups
N. Demyanenko (Moskow, Russian Federation), A. Mihail (Moskow, Russian Federation), N. Makaryants (Moskow, Russian Federation), E. Vladimirova (Moskow, Russian Federation), A. Egorova (Moskow, Russian Federation), A. Akhmedova (Moskow, Russian Federation)
| |
HLA Associations in Czech Patients with Sarcoidosis
K. Sikorová (Olomouc, Czech Republic), V. Zizková (Olomouc, Czech Republic), L. Kocourková (Olomouc, Czech Republic), A. Strnad (Olomouc, Czech Republic), M. Doubková (Brno, Czech Republic), M. Petrek (Olomouc, Czech Republic), M. Petrek (Olomouc, Czech Republic)
| |
Influence of HLA class II DRB1*/DQB1* alleles in phenotypes of Indian patients of sarcoidois.
D. Rosha (GAUTAM BUDDHA NAGAR, India), M. Chowdhry (New Delhi, India), I. Gupta (Noida, India), d. rosha (New Delhi, India)
| |
Comorbidity of sarcoidosis in mountainous regions of Western Ukraine: a based-cohort (n=592) patients analysis
K. Shvets (Ivano-Frankivsk, Ukraine), M. Ostrovskyy (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
| |
Seasonality of hypercalcemia - A population-based study on patients with pulmonary sarcoidosis
J. Rødsgaard (Odense C, Denmark), D. Pilsgaard Henriksen (Odense C, Denmark), C. B. Laursen (Odense C, Denmark), J. Rømhild Davidsen (Odense C, Denmark)
| |
The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases
P. Cameli (Siena (SI), Italy), C. Caffarelli (Siena (SI), Italy), M. D'Alessandro (Siena (SI), Italy), L. Bergantini (Siena (SI), Italy), M. Armati (Siena (SI), Italy), M. Tomai Pitinca (Siena (SI), Italy), P. Sestini (Siena (SI), Italy), S. Gonnelli (Siena (SI), Italy), E. Bargagli (Siena (SI), Italy)
| |
The features of sarcoidosis in owerweight patients.
E. Shchepikhin (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), A. Zaitseva (Moscow, Russian Federation), N. Makaryants (Moscow, Russian Federation)
| |
Cardio-pulmonary exercise test and 1-minute sit-to-stand test correlation in patients with sarcoidosis.
I. Kokkonouzis (Peristeri - Athens, Greece), I. Pantou (Athens, Greece), D. Papadopoulos (Athens, Greece), N. Tzogkas (Athens, Greece)
| |
Löfgren syndrome in patients with sarcoidosis: 25 years` observational study in Kharkiv, Ukraine
P. Poteiko (Kharkiv, Ukraine), O. Konstantynovska (Kharkiv, Ukraine)
| |
Comparative review of older-onset and younger-onset sarcoidosis in endobronchial biopsy-confirmed cases
M. Brennan (Galway, Ireland), S. Phelan (Galway, Ireland), D. Breen (Galway, Ireland)
| |
An Audit on the Screening of Biopsy Confirmed Sarcoidosis in a University Hospital
N. Boyle (Dublin, Ireland), A. Kirk (Dublin, Ireland), C. Larney (Dublin, Ireland), T. Mcenery (Dublin, Ireland)
| |
Prevalence of small fiber neuropathy in patients with sarcoidosis in an outpatient setting.
N. Bernardinello (Padova, Italy), E. Cocconcelli (Padova, Italy), E. Balestro (Padova, Italy), P. Spagnolo (Padova, Italy)
| |
Quality of Life in Patients with Sarcoidosis Combined with Irritable Bowel Syndrome
O. Semendyayeva (Donetsk, Ukraine), A. Zeinalova (Donetsk, Ukraine), L. Tsirkovskaya (Donetsk, Ukraine), N. Monogarova (Donetsk, Ukraine)
| |
Fatigue, coping, anxiety and depression in patients with sarcoidosis
L. Charvoz (Lausanne, Switzerland), A. Veyre (Lausanne, Switzerland), S. Châtelain (Lausanne, Switzerland), N. Domon (Lausanne, Switzerland), D. Novel (Lausanne, Switzerland), M. Wiamsemsky (Lausanne, Switzerland), S. Ahmetovic (Lausanne, Switzerland), C. Daccord (Lausanne, Switzerland), A. Ogna (Lausanne, Switzerland), L. Nicod (Lausanne, Switzerland)
| |
Short term treatment response in pulmonary sarcoidosis – a prospective study
A. Thomas (Pathanamthitta, India), B. Isaac (Vellore, India), D. Christopher (Vellore, India), L. Vimala (Vellore, India), R. Gupta (Vellore, India)
| |
The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
I. Merenkova (Kyiv, Ukraine), V. Gavrysyuk (Kyiv, Ukraine), Y. Dziublyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine)
| |